METHODS	One hundred patients ( 80 males , 20 females ; median age 65.8 years , range 48-79 years ) eligible for intravesical prophylaxis of superficial bladder cancer recurrences were randomized to receive intravesical therapy using a standard catheter ( group A , n = 50 ) or a hydrophilic catheter ( group B , n = 50 ) .\